Overview

Humanized Liver Mice Model Market Introduction Humanized liver mice model market value over USD 115 Million by 2027 end and register a CAGR of over 5.5% from 2020 to 2027. To improve the understanding of mammalian and human genome function and have effective therapies designed, humanized liver mice market plays a vital role. The rising need for development and efficient research and useful results, the global market for humanized liver mice is growing. High expenses and technical requirements may restrict the market. Rapid modernisation which promotes the genetic engineering of mouse genomes such as the development of knock-out mouse, knock-in mouse as well as the transgenic mouse has led to lucrative trade. To encourage the robust genetic modification of mice, advancements in technology are rapid, which promotes the engineering of new immune-deficient mice models for capitalizing on the discovery of novel approaches to enhance the engraftment of human cells or tissues. Engrafting the mouse liver with human hepatocytes and mouse bone marrow with human hematopoietic stem cells is a great discovery, expected to propel the market. The developed nations have higher research facilities and thus the market finds great application there. Markets of North America and Europe are high growth pockets and are predicted to grow at highest CAGR during the forecast period. Market palyers are incessantly competing for a significant value share and expansion of their global outreach by investing in technologies. Major firms operating in the market are The Jackson Laboratory, Crown Bioscience Inc. (JSR Life Science), Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc., Ltd., GenOway, Creative Animodel, and Horizon Discovery Group plc. Humanized Liver Mice Model Market Segmentation: By Application

● Pharmacokinetics Studies

● In-vivo Liver Toxicity Testing

● Drug Metabolism Studies

● Others By Model

● uPA-SCID

● FRG KO Mice

● TK-NOG Mice

● Other Models By End User

● Pharmaceutical Companies

● Biotechnology Companies

● Contract Research Organizations (CRO’s)

● Academic & Research Institutes By Region:

● Europe

● North America

● APAC

● Latin America

● Rest of World Competitive Landscape:

● Tier 1 players- established companies in the market with a major market share

● Tier 2 players

● Emerging players which are growing rapidly

● New Entrants FutureWise Key Takeaways

● Growth prospects

● SWOT analysis

● Key trends

● Key data points affecting market growth Objectives of the Study:

● To provide an exhaustive analysis on the humanized liver mice model based on application, model, end user and region

● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

● To evaluate and forecast micro-markets and overall market

● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

● Profiling of companies to evaluate their market shares, strategies, financials and core competencies